Frequently Overlooked Components of a DOT Drug Testing Policy
This information is provided for educational purposes only. Reader retains full responsibility for the use of the information contained herein.
You may think your DOT drug and alcohol testing policy is compliant — but you might be surprised.
However, unless you routinely review policies, you could miss critical regulatory requirements. Most employers understand the broad framework of U.S. Department of Transportation (DOT) testing rules — types of tests, Medical Review Officer (MRO) requirements, laboratory standards, and general procedures.
It’s often the technical details buried in the regulations that create compliance gaps.
Employers are responsible for implementing a testing policy that complies with 49 CFR Part 40 and the applicable DOT agency regulations or United States Coast Guard (USCG) rules. Even minor omissions can create serious exposure.
A non-compliant policy can:
- Disrupt your drug and alcohol testing program
- Trigger audit findings
- Result in substantial fines
- Jeopardize federal contracts or funding
Whether due to outdated language, regulatory changes, misunderstanding, or simple oversight, the result is the same: a vulnerable testing program.
Below are some of the most common compliance pitfalls we see.
- Failing to Identify the Designated Employer Representative (DER)
This is a simple — yet frequently overlooked — requirement.
The DOT requires employers to designate a Designated Employer Representative (DER) and clearly identify this individual in the written policy.
The DER:
- Answers employee questions about the drug and alcohol testing program
- Serves as the liaison between the employer and service agents (TPA, clinic, laboratory, MRO)
- Receives and acts on test results
- Manages removals from safety-sensitive duties
- Oversees return-to-duty and follow-up processes
Because the DER is the central authority for the testing program, the policy must clearly include the DER’s contact information. Without it, employees have no defined channel to ask questions, report concerns, or seek clarification—creating a direct compliance risk..
Best practice also calls for identifying a secondary or backup DER within the policy. If the primary DER is unavailable, having a designated alternate ensures continuity, timely decision-making, and uninterrupted program administration. Proactive planning for these situations helps prevent delays and protects your organization from avoidable compliance gaps.
- Failing to Clearly Define Safety-Sensitive Employees
Each DOT agency — including the Federal Motor Carrier Safety Administration (FMCSA) requires testing of employees performing specific safety-sensitive functions.
Your policy must clearly identify which employee classifications are covered.
For example, under FMCSA regulations, drivers are subject to testing if they operate a commercial motor vehicle (CMV) that:
- Has a gross combination weight rating of 26,001 pounds or more, including a towed unit over 10,000 pounds;
- Has a gross vehicle weight rating of 26,001 pounds or more;
- Is designed to transport 16 or more passengers, including the driver; or
- Is of any size and is used in the transportation of materials found to be hazardous for the purposes of the Hazardous Materials Transportation Act and which require the motor vehicle to have a placard under the Hazardous Materials Regulations. If your policy fails to specify these categories, you are out of compliance — and covered employees may not even realize they are subject to DOT testing requirements.
Clear definitions protect both the employer and the employee.
- Mixing DOT and Non-DOT Testing Requirements
Employers may choose to conduct testing beyond DOT requirements — such as testing for additional substances. However, DOT and Non-DOT testing programs must remain completely separate.
Common mistakes include:
- Listing additional drugs under the DOT section of the policy
- Using DOT custody and control forms for Non-DOT testing
- Failing to clarify which tests are conducted under company authority
If both DOT and Non-DOT testing are conducted:
- The DOT test must always be conducted and completed first.
- The employee must be informed when the DOT portion is complete.
- Any additional testing must be clearly conducted under the company’s Non-DOT authority.
- Employers must never use the Federal Drug Testing Custody and Control Form (CCF) or DOT Alcohol Testing Form (ATF) for Non-DOT tests.
Blurring these lines is a major compliance violation and a frequent audit finding.
- Omitting Required Educational Information on Drugs and Alcohol
One of the most puzzling mistakes we see is eliminating required educational language from the policy.
Some employers assume this content can be covered solely in supervisor training. It cannot.
DOT regulations require your written policy to include:
- The effects of alcohol and controlled substance use on health, work, and personal life
- Signs and symptoms of alcohol or drug misuse (for both the employee and coworkers)
- Available methods of intervention
- Information about confrontation and referral processes
- Details about employee assistance programs (EAPs), if available
This information must be included directly in the policy — not just presented during training.
Why Policy Compliance Matters More Than Ever
DOT audits are detailed. Investigators don’t just look at your testing records — they scrutinize your written policy. A policy that is missing required elements signals weak oversight and may lead to deeper program review.
Compliance is not optional. It is a regulatory obligation.
Is Your DOT Policy Audit-Ready?
If your policy hasn’t been reviewed recently — or if it was copied from a template years ago — now is the time to ensure it aligns with current Part 40 and agency-specific regulations.
A proactive policy review can:
- Identify compliance gaps.
- Reduce audit risk.
- Protect federal funding.
- Strengthen your workplace safety culture.
Don’t assume your policy is compliant — verify it.
Need a DOT policy review or update? A comprehensive compliance assessment can help ensure your drug and alcohol testing program stands up to regulatory scrutiny and protects your organization from unnecessary risk.
AVOID THESE COMMON PITFALLS! If you haven’t reviewed your policy recently, you may be out of compliance with the law. Contact DrugPak to evaluate the components of your testing program. We are here to help.
© 2010-2026 DrugPak – No portion of this article may be reproduced, retransmitted, posted on a website, or used in any manner without the written consent of DrugPak. When permission is granted to reproduce this article in any way, full attribution to the author and copyright holder is required.
